what is the optimal value for the phred score for rna seq data?
Unconfigured Ad
Collapse
X
-
It's probably good you're not doing too much on DE/transcript reconstruction as I would have said the read numbers were a little low for anything other than gene level expression testing.Originally posted by arcolombo698 View PostThank you very much for your response
It is RNA-seq experiment.
As already pointed out, you should be fine to do variant calling from the expressed genes, where there is sufficient depth - but you will want to put some kind of depth threshold for the variant calling (also there will be instances of allele specific expression and presumably RNA editing in the data). With different numbers of reads per sample, obviously some samples will have better coverage than others. For differential expression studies this is not so much of an issue when the data is normalised to the number of mapped reads anyway.Last edited by Bukowski; 12-25-2013, 06:58 AM.
Comment
-
-
thank you for the response
are there resources recommended that gives insight about understanding sufficient depth of reads for variant calling and other common problems? it seems sufficient to have read lengths of 13M.. i have a sample read with 7M , this seems also low.
these samples have all passed QC with no duplicated sequences (all the repeated sequences have been trimmed out...dont want duplicated sequences)
would appreciate resources on how to properly process VCF , and also how to analyze the VCF results, error checking etc...
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
30 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
213 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
79 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment